Eli Lilly and Co.

Eli Lilly and Co. is a prominent U.S. pharmaceutical company known for its innovative research and development in various therapeutic areas, including diabetes, oncology, and immunology. Recently, the company has been in the news for its new drug, orforglipron, which showed promising results in clinical trials for weight loss and blood sugar reduction, positioning it as a competitor to the widely used Ozempic.